Core Viewpoint - The company, Saifen Technology (688758.SH), anticipates a significant increase in net profit for the first three quarters of 2025, projecting a range of 90 million to 98 million RMB, representing a year-on-year growth of 65% to 80% compared to the previous year [1] Financial Performance - The expected net profit for the first three quarters of 2025 is estimated to be between 90 million and 98 million RMB, an increase of 35.51 million to 43.51 million RMB from the same period last year [1] Business Strategy - The company focuses on two core areas: analytical chromatography and industrial purification, driving innovation through technology [1] - Saifen Technology is leveraging the domestic substitution strategy by actively expanding its customer base and enhancing cooperation with existing clients to increase repeat purchases [1] - The dual approach of acquiring new clients while deepening relationships with existing ones has led to further expansion in operational scale and stable improvement in profitability [1]

Core Insights - The company, Saifen Technology (688758.SH), anticipates a net profit attributable to shareholders of the parent company between 90 million to 98 million RMB for the first three quarters of 2025, representing an increase of 35.51 million to 43.51 million RMB compared to the same period last year, which translates to a year-on-year growth of 65% to 80% [1] Group 1 - The company focuses on two core areas: analytical chromatography and industrial purification, driven by technological innovation [1] - The company is leveraging the domestic substitution strategy, actively expanding its customer base while also enhancing the repurchase conversion of existing customer projects [1] - The dual approach of expanding new customer projects and deepening cooperation with existing clients has led to further expansion of the company's operational scale and stable upward profitability [1]

2、实现归属于母公司所有者的净利润为 9,000.00 万元到 9,800.00 万元， 与上年同期相比，将增加人民币 3,551.21 万元到 4,351.21 万元，同比增长 65% 到 80%。 证券代码：688758 证券简称：赛分科技 公告编号：2025-037 苏州赛分科技股份有限公司 2025年前三季度业绩预告的自愿性披露公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 9 月 30 日。 （二）业绩预告情况 经苏州赛分科技股份有限公司（以下简称"公司"）财务部门初步测算，预 计公司 2025 年前三季度： 1、实现营业收入 29,500.00 万元到 31,700.00 万元，与上年同期相比，将 增加人民币 7,646.74 万元到 9,846.74 万元，同比增长 35%到 45%。 四、风险提示 截至本公告日，公司不存在影响本次业绩预告内容准确性的重大不确定因素， 本次业绩预告未经注册会计师审计。 3、实现归属于 ...

Core Viewpoint - The company expects to achieve significant revenue and profit growth in the first three quarters of 2025, driven by technological innovation and strategic market expansion [1] Financial Performance - Projected revenue for the first three quarters of 2025 is between 295 million to 317 million yuan, representing a year-on-year growth of 35% to 45% [1] - Expected net profit attributable to the parent company is between 90 million to 98 million yuan, indicating a year-on-year increase of 65% to 80% [1] - The net profit attributable to the parent company, excluding non-recurring gains and losses, is projected to be between 81 million to 89 million yuan, reflecting a year-on-year growth of 50% to 65% [1] Business Strategy - The company focuses on two core areas: analytical chromatography and industrial purification, leveraging technological innovation to enhance product performance and core technology development [1] - The company is capitalizing on the domestic substitution strategy by actively expanding new customer projects and increasing market coverage [1] - There is a steady push to convert existing customer projects into repeat purchases, enhancing customer cooperation and loyalty [1]

Core Viewpoint - The company, Saifen Technology, anticipates a significant increase in net profit for the first three quarters of the year, driven by strategic initiatives and technological innovation [1] Financial Performance - The expected net profit attributable to shareholders for the first three quarters is projected to be between 90 million and 98 million yuan, representing a year-on-year increase of 65% to 80% [1] - The expected net profit after deducting non-recurring gains and losses is projected to be between 81 million and 89 million yuan, indicating a year-on-year increase of 50% to 65% [1] Strategic Initiatives - The company focuses on two core areas: analytical chromatography and industrial purification, leveraging technological innovation to enhance product performance and core technology development [1] - The company is capitalizing on the domestic substitution strategy by actively expanding new customer projects and increasing market coverage while also promoting the repurchase conversion of existing customer projects to deepen customer cooperation [1] Operational Expansion - The dual strategy of expanding new customer projects and enhancing existing customer relationships has led to further expansion of the company's operational scale and stable improvement in profitability [1]

Core Viewpoint - On October 13, 2023, Saifen Technology experienced a decline of 1.14% in stock price, with a trading volume of 29.8868 million yuan, indicating a potential market reaction to recent financial activities [1] Financing Summary - On the same day, Saifen Technology had a financing buy-in amount of 2.3574 million yuan, with a net financing buy of 896,300 yuan after repaying 1.4611 million yuan [1][2] - As of October 13, the total financing and securities lending balance for Saifen Technology was 43.8037 million yuan, accounting for 5.96% of its circulating market value [2] Business Overview - Saifen Technology, established on March 16, 2009, is located in the Suzhou Industrial Park, Jiangsu Free Trade Zone, and specializes in the research and production of liquid chromatography materials for drug analysis and purification [2] - The company's revenue composition includes: Industrial Purification Segment (33.10%), Industrial Purification Fillers (32.65%), Analytical Chromatography Segment (16.73%), Analytical Chromatography Columns (13.31%), and other minor segments [2] Financial Performance - For the period from January to June 2025, Saifen Technology reported a revenue of 183 million yuan, representing a year-on-year growth of 19.76%, and a net profit attributable to shareholders of 53.6592 million yuan, reflecting a 40.91% increase compared to the previous year [3] Shareholder Information - As of June 30, 2025, the number of shareholders for Saifen Technology was 10,500, a decrease of 4.63% from the previous period, with an average of 3,779 circulating shares per person, an increase of 4.86% [3] - The total cash dividends distributed by Saifen Technology since its A-share listing amounted to 27.9031 million yuan [4] - The largest circulating shareholder as of June 30, 2025, was Southern Science and Technology Innovation Mixed Fund, holding 791,100 shares, a decrease of 893,600 shares from the previous period [4]

Core Viewpoint - The announcement from Saifen Technology indicates that core technical personnel Yang Ke has officially retired due to reaching the legal retirement age, and he will no longer be recognized as a core technical staff member or hold any position within the company [1] Company Summary - Yang Ke's retirement marks a significant change in the company's technical leadership, as he was previously recognized as a core technical personnel [1] - The company will need to address the potential impact of this leadership change on its ongoing projects and technological development [1]

中信证券股份有限公司 关于苏州赛分科技股份有限公司 核心技术人员离职的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐人"）作为苏州赛分 科技股份有限公司（以下简称"赛分科技"、"公司"）首次公开发行股票并在科 创板上市的保荐人，根据《首次公开发行股票注册管理办法》《上海证券交易所 科创板股票上市规则》等有关法律法规和规范性文件的要求，对公司核心技术人 员离职事项进行了专项核查，具体情况及核查意见如下： 一、杨克先生离职的具体情况 公司核心技术人员杨克先生因达到法定退休年龄，于近日正式退休，公司不 再认定其为核心技术人员，且杨克先生不再担任公司任何职务。 （一）核心技术人员的具体情况 （三）竞业限制及保密情况 根据公司与杨克先生签署的《竞业限制及保密协议》，双方对保密内容、竞 业限制等事项进行了明确的约定。截至本核查意见出具之日，公司未发现杨克先 生有违反《竞业限制及保密协议》的情形。 二、核心技术人员离职对公司的影响 公司高度重视研发工作，不断完善研发体系建设，研发运营团队结构完整， 研发平台各部门各司其职，公司的技术研发与生产运营工作均正常开展，不存在 对特定核心技术人员单一依赖的情形。目前， ...

证券代码：688758 证券简称：赛分科技 公告编号：2025-036 重要内容提示： 一、杨克先生离职的具体情况 公司核心技术人员杨克先生因达到法定退休年龄，于近日正式退休，公司不 再认定其为核心技术人员，且杨克先生不再担任公司任何职务。公司及董事会对 杨克先生任职期间为公司发展所做出的努力和贡献表示衷心感谢。 1、核心技术人员的具体情况 杨克，赛分科技研究院士，美国布兰迪斯大学（Brandeis）博士，麻省理工 学院（MIT）博士后。1995 年至 2008 年，先后供职于美国 Memorial Sloan-Kettering Cancer Center，Pharmacoepeia, Inc.，Message Pharmaceutical, Inc. 和 Astrazeneca 苏州赛分科技股份有限公司 关于核心技术人员离职的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 苏州赛分科技股份有限公司（以下简称"赛分科技"或"公司"）核心 技术人员杨克先生因达到法定退休年龄，于近日正式退休离职，公司不 再认定其为核心 ...

Group 1 - Core technical personnel Yang Ke has officially retired due to reaching the legal retirement age and will no longer hold any position in the company [1] - As of the report, the market capitalization of the company is 7.7 billion yuan [1] Group 2 - For the fiscal year 2024, the revenue composition of the company is as follows: drug analysis accounts for 40.2%, antibody drugs for 20.85%, insulin/peptide/GLP-1 for 18.18%, recombinant proteins for 13.73%, and others for 6.6% [1]